WuXi NextCODE to Offer The New Pan-Cancer TSO 500 Biomarker Assay from Illumina
WuXi NextCODE offers access to Illumina's TruSightTM Oncology 500 (TSO 500).
Louis brings two decades of proven sales, marketing and team management expertise at Becton Dickinson, Pfizer and Sanofi to oversee the growth of WuXi NextCODE’s China business and operations.
We're proud to announce a new partnership with Rhythm Pharmaceuticals that will accelerate drug discovery for rare genetic obesity disorders.
How will WuXi NextCODE bring AI to the forefront of drug discovery and development? CEO Hannes Smarason explains.
Geneticists can use the latest AI and Big Data analytics technology to study, diagnose, and even treat cancer.
Dr. Christina Waters’ expertise in translational medicine and building global networks and cohorts will extend the reach and benefits directly to patients, families and disease organizations.
An in-depth feature published by Hong Kong’s premiere business and culture magazine, The Peak, about how WuXi NextCODE serves as "the Google of genomic data."
Boston Children’s Hospital and Harvard Medical School-led study in Science leverages WuXi NextCODE's expertise in feature selection and pathway enrichment. Study shows how individual neurons accumulate mutations over time and how this process differs between normally aging people and those with early-onset disease.
The 2017 Scrip Awards recognize WuXi NextCODE for enabling the pharmaceutical industry to take advantage of genomics.
How institutions are applying genomic analysis to precision medicine efforts from Pennsylvania to Qatar.
We've sequenced over 11K pediatric genomes with the Fudan Children's Hospital in China. Here's a glimpse into how they harness the genome to deliver rare disease diagnoses faster.
At the ASHG 2017 "Genomes for Breakfast" breakout sessions, panelists discuss how population genomics and rare disease diagnostics are advancing public health.
Precision medicine fails when new genetic discoveries aren't communicated to patients who need to know them. This case shows how two patients could have avoided having psychotic episodes if clinical institutions had a better system for communicating new gene variants associated with mental illness.